Regulations.gov document
How Should Liver Injury and Dysfunction Caused by Drugs Be Measured, Evaluated, and Acted…
Notice · FDA-2008-D-0128 · posted Jan 15, 2016
Key facts
| Document ID | FDA-2008-D-0128-0009 |
|---|---|
| Title | How Should Liver Injury and Dysfunction Caused by Drugs Be Measured, Evaluated, and Acted Upon in Clinical Trials? |
| Document type | Notice |
| Subtype | Public Meetings |
| Agency | FDA |
| Docket | FDA-2008-D-0128 |
| Posted | Jan 15, 2016 |
| Federal Register citation | 81 FR 2222 |
| FR document number | 2016-00690 |
| Comment period opens | Jan 15, 2016 |
| Effective date | Jan 15, 2016 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: